首页> 外国专利> compound or a pharmaceutically acceptable salt or solvate thereof, pharmaceutical composition, use of a compound, and method for treating or preventing neurological and psychiatric disorders associated with glutamate dysfunction in an animal

compound or a pharmaceutically acceptable salt or solvate thereof, pharmaceutical composition, use of a compound, and method for treating or preventing neurological and psychiatric disorders associated with glutamate dysfunction in an animal

机译:化合物或其药学上可接受的盐或溶剂化物,药物组合物,化合物的用途以及治疗或预防与动物谷氨酸功能障碍有关的神经和精神疾病的方法

摘要

COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE OF THE SAME, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, AND, METHOD FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISTURBANCES ASSOCIATED WITH THE SUCH AGAINST OR DISEASES OF GLUTAMINE; where Ar ^ 1 ^, Ar ^ 2 ^, A, X, Y, m, n and R ^ 1 ^ to R ^ 2 ^ are described in the specification.
机译:同样的化合物或药学可接受的盐或溶剂化物,药物组合物,化合物的使用以及治疗或预防与谷氨酰胺这种或多种疾病有关的神经和精神障碍的方法;在说明书中描述了Ar ^ 1 ^,Ar ^ 2 ^,A,X,Y,m,n和R ^ 1 ^至R ^ 2 ^。

著录项

  • 公开/公告号BRPI0706401A2

    专利类型

  • 公开/公告日2011-03-29

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR2007PI06401

  • 申请日2007-01-05

  • 分类号C07D211/70;C07D213/30;C07D213/61;C07D213/74;C07D213/85;C07D233/54;C07D239/26;C07D241/12;C07D277/24;C07D295/10;C07D295/14;

  • 国家 BR

  • 入库时间 2022-08-21 18:07:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号